Compatibility of 17-α-Estradiol, Betamethasone, Finasteride, Melatonin, Prednicarbate, and Spironolactone in TrichoFoam™ - a Foaming Vehicle for Personalized Alopecia Treatments
用户eDADl3UTx-7A
1个月前
39
10
已关闭
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/39642029
其他信息:
PMID: 39642029
作者: Bruna Marianni; Hudson Polonini; Bruna Marianni; Bruna Marianni; Hudson Polonini
摘要: Objective: This study evaluates the physicochemical compatibility of six active pharmaceutical ingredients (APIs) - 17-a-estradiol, betamethasone, finasteride, melatonin, prednicarbate, and spironolactone - in TrichoFoam™, a foaming vehicle designed for personalized alopecia treatments.
